Insights

Translational Oncology Panome Bio’s recent partnership with TD2 International to advance translational oncology in Missouri signals a strong entry point for multi-omics services in cancer research collaborations and contract work.

MassID Platform The launch of MassID, a cloud-based platform for untargeted LC/MS metabolomics data processing and interpretation, offers a scalable software-as-a-service angle to target metabolomics-focused labs and CROs seeking faster data insights.

Integrated Multi-Omics Their industry-leading integrated multi-omics approach, supported by a proprietary data integration platform and connections database, creates opportunities to upsell comprehensive multi-omics projects to customers needing end-to-end analyses.

Transparency and Speed With transparent methods and 4-6 week delivery of raw data and reports, Panome Bio appeals to researchers who value reproducibility and timeliness, suggesting a fit for pilot studies and sponsored collaborations.

Strategic Leadership Board-level additions from Telegraph Hill Partners and a funding base indicate growing strategic momentum and investor confidence, which can facilitate co-development partnerships and larger-scale contracts.

Similar companies to Panome Bio

Panome Bio Tech Stack

Panome Bio uses 8 technology products and services including Google Ads, HubSpot Analytics, Amazon Web Services, and more. Explore Panome Bio's tech stack below.

Panome Bio's Email Address Formats

Panome Bio uses at least 2 email formats:
Panome Bio Email FormatsExamplePercentage
First.Last@panomebio.comJohn.Doe@panomebio.com
95%
Last.F@panomebio.comDoe.J@panomebio.com
5%

Frequently Asked Questions

What is Panome Bio's official website and social media links?

Minus sign iconPlus sign icon
Panome Bio's official website is panomebio.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Panome Bio generate?

Minus sign iconPlus sign icon
As of October 2026, Panome Bio's annual revenue is estimated to be $10M - $25M.

What is Panome Bio's SIC code and NAICS code?

Minus sign iconPlus sign icon
Panome Bio's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Panome Bio have currently?

Minus sign iconPlus sign icon
As of October 2026, Panome Bio has approximately 26 employees across 4 continents, including North America, Africa and Europe. Key team members include Director, Business Development - Europe: K. H. Explore Panome Bio's employee directory with LeadIQ.

What industry does Panome Bio belong to?

Minus sign iconPlus sign icon
Panome Bio operates in the Biotechnology Research industry.

What technology does Panome Bio use?

Minus sign iconPlus sign icon
Panome Bio's tech stack includes Google Ads, HubSpot Analytics, Amazon Web Services, Docker, Microsoft 365, Google Cloud Platform, Microsoft Azure and WP Engine.

What is Panome Bio's email format?

Minus sign iconPlus sign icon
Panome Bio's email format typically follows the pattern of First.Last@panomebio.com. Find more Panome Bio email formats with LeadIQ.

How much funding has Panome Bio raised to date?

Minus sign iconPlus sign icon
As of October 2026, Panome Bio has raised $12M in funding. The last funding round occurred on Nov 21, 2024 for $6M.

When was Panome Bio founded?

Minus sign iconPlus sign icon
Panome Bio was founded in 2022.
Panome Bio logo

Panome Bio

Biotechnology ResearchMissouri, United States11-50 Employees

Panome Bio is a biotechnology research company based in St. Louis, Missouri, focusing on multi-omics services that integrate metabolomics, proteomics, transcriptomics, and other omics data. The firm emphasizes transparency and provides customers with personalized data reports alongside access to all methods and raw data within a four- to six-week timeframe, supporting researchers seeking clarity, speed, and insight in omics analyses. It positions itself as an industry leader through an integrated approach that combines a proprietary data integration platform and a known connections database to unlock the full potential of multi-omics for translational and exploratory research. The company serves researchers and institutions requiring comprehensive, end-to-end omics workflows and interpretable results, aiming to streamline discovery and enhance analytical insight. A notable recent development includes the launch of MassID, a cloud-based platform designed to improve processing and interpretation of untargeted LC/MS metabolomics data, reflecting ongoing expansion of its analytical capabilities. Panome Bio operates in the biotechnology research sector with a mid-sized team, offering services that span generation, integration, and interpretation of multi-omics data.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2022
Employees
11-50

Section iconFunding & Financials

  • $12M

    Panome Bio has raised a total of $12M of funding over 2 rounds. Their latest funding round was raised on Nov 21, 2024 in the amount of $6M.

  • $10M - $25M

    Panome Bio's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.